An Update in the Use of Antibodies to Treat Glioblastoma Multiforme
Glioblastoma is a deadly brain disease and modest improvement in survival has been made. At initial diagnosis, treatment consists of maximum safe surgical resection, followed by temozolomide and chemoirradiation or adjuvant temozolomide alone. However, these treatments do not improve the prognosis a...
Main Authors: | Norma Y. Hernández-Pedro, Edgar Rangel-López, Gustavo Vargas Félix, Benjamín Pineda, Julio Sotelo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Autoimmune Diseases |
Online Access: | http://dx.doi.org/10.1155/2013/716813 |
Similar Items
-
Glioblastoma multiforme : An update
by: K I Mathai, et al.
Published: (2014-01-01) -
Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?”
by: Aisling M. Glynn, et al.
Published: (2019-08-01) -
TREATING GLIOBLASTOMA MULTIFORME USINGMULTICOMPONENT SILICA NANOPARTICLES
by: Turan, Oguz Alp
Published: (2019) -
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01) -
Glioblastoma Multiforme
by: Jonas M. Sheehan, et al.
Published: (2012-01-01)